Sarcona convicted in supplement scam
This article was originally published in The Tan Sheet
Executive Summary
A federal jury convicts Frank Sarcona, a Boca Raton, Fla., businessman of defrauding more than 100,000 consumers out of more than $16 million "through his fraudulent sales techniques" relating to a supplement product called Lipoban, says Jeffrey Sloman, U.S. Attorney for the Southern District of Florida. Sarcona's sentencing is scheduled for Jan. 15, 2010. Sloman's Oct. 30 release says Sarcona - also known as Frank Sarcone and Dave Johnson - violated a 1999 final injunction order prohibiting his connection with the sale of a supplement and requiring him to post a $5 million performance bond before becoming involved with a weight-loss service or product. The injunction order stemmed from the lawsuit FTC v. SlimAmerica (1"The Tan Sheet" Feb. 10, 1997)
You may also be interested in...
SlimAmerica Super Formula weight loss products target of FTC suit.
SLIMAMERICA ORDERED TO HALT BUSINESS: SUPER FORMULA WEIGHT LOSS PRODUCTS advertising claims are "false and misleading," the Federal Trade Commission charged Feb. 3 after filing suit Jan. 24 against SlimAmerica. A temporary restraining order issued by a Miami federal court also freezes the assets of the Deerfield Beach, Fla.-based company. FTC's request to permanently enjoin SlimAmerica is scheduled for a hearing on Feb. 10.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.